Adhesion of Children and Adolescents Treated for Cancer to Personalized Support in Adapted Physical Activity Program

Launched by UNIVERSITY HOSPITAL, GRENOBLE · Jan 26, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how to help children and teenagers with cancer stay active during their treatment. Since 2022, a special program called Adapted Physical Activity (APA) has been offered to all young patients newly diagnosed with cancer or experiencing a relapse. The goal of the study is to see what motivates these children and their parents to join the program and what might hold them back. Researchers will ask questions before the program starts and again after 4 to 6 months to understand their experiences better.

To join this study, children between the ages of 3 and 17 who are receiving care at Grenoble Alpes University Hospital can participate if they have a new cancer diagnosis or a relapse and haven't been in an APA program before. It’s important that both the child and their parents understand French and agree to take part. However, children with certain health issues that prevent them from being active, as determined by their doctor, will not be eligible. The study aims to create better support and tools to encourage long-term participation in physical activity for young cancer patients, helping them to feel better as they go through treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged 3 years to under 18 years under care at Grenoble Alpes University Hospital
• • New cancer diagnosis or relapse in the absence of previous APA treatment
• * All cancer pathologies:
• • Diagnosis of acute or chronic hematological malignancy OR Central nervous system tumors OR Other solid tumors
• • Regardless of therapeutic pathway
• • Parents and patient over 5 years old understanding french langage
• • Patient and parents who have not objected to participation after being informed
• Exclusion Criteria:
• • Patient with a strict medical contraindication to physical activity identified by the referring physician or another specialist physician, particularly the sports physician (unstabilized heart or lung disease, uncontrolled diabetes, etc.)